dCasMINI-mediated therapy rescues photoreceptors degeneration in a mouse model of retinitis pigmentosa
Science Advances · 2024
DOI: 10.1126/sciadv.adn7540 ↗At a glance
Journal article in Science Advances, 2024. Written by Qing Wang and 14 co-authors. Institution: Byers Eye Institute, Department of Ophthalmology, Stanford University, Palo Alto, CA 94304, USA. Major MEDLINE topics: Retinitis Pigmentosa, Disease Models, Animal, Cyclic Nucleotide Phosphodiesterases, Type 6, Genetic Therapy. Cited 9 times so far (Crossref); 45 references. The full text is freely available in PubMed Central. Funded by: NEI NIH HHS.
Abstract (original language)
Retinitis pigmentosa (RP) is characterized by degeneration of rod and cone photoreceptors that progresses to irreversible blindness. Now, there are no mutation-agnostic approaches to treat RP. Here, we utilized a single adeno-associated virus (AAV)–based CRISPR activation system to activate phosphodiesterase 6B (Pde6b) to mitigate the severe degeneration in Pde6a nmf363 mice. We demonstrate that transcriptional activation of Pde6b can rescue the loss of Pde6a , with preservation of retinal structure, restoration of electroretinography responses, and improvement of visual function as assessed by optokinetic response and looming-induced escape behaviors. These findings demonstrate the therapeutic potential of a dCasMINI-mediated activation strategy that provides a mutation-independent treatment for retinal degeneration. This study offers a promising therapeutic approach for RP and potentially other forms of genetic diseases.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Byers Eye Institute, Department of Ophthalmology, Stanford University, Palo Alto, CA 94304, USA.
- Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.
- Department of Molecular and Cellular Physiology, Stanford University, Stanford, CA 94305, USA.
- Department of Ophthalmology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
- Sarafan ChEM-H, Stanford University, Stanford, CA 94305, USA.
- Chan Zuckerberg Biohub-San Francisco, San Francisco, CA 94158, USA.
ORCID profiles: Qing Wang, Xiaoshu Xu, Chien-Hui Lo, Ke Ning, Tia J Kowal, Biao Wang, Sui Wang, Yang Sun
Funding
- NEI NIH HHS
Cite
APA
Wang, Q., Xu, X., Chen, S., Lu, R., Li, L., Lo, C. H., Liu, Z., Ning, K., Li, T., Kowal, T. J., Wang, B., Hartnett, M. E., Wang, S., Qi, L. S., & Sun, Y. (2024). dCasMINI-mediated therapy rescues photoreceptors degeneration in a mouse model of retinitis pigmentosa. Science Advances. https://doi.org/10.1126/sciadv.adn7540
Vancouver
Wang Q, Xu X, Chen S, Lu R, Li L, Lo CH, et al. dCasMINI-mediated therapy rescues photoreceptors degeneration in a mouse model of retinitis pigmentosa. Science Advances. 2024. doi:10.1126/sciadv.adn7540
BibTeX
@article{Wang2024,
author = {Wang, Qing and Xu, Xiaoshu and Chen, Siyu and Lu, Rui and Li, Liang and Lo, Chien-Hui and Liu, Zhiquan and Ning, Ke and Li, Tingting and Kowal, Tia J and Wang, Biao and Hartnett, Mary E and Wang, Sui and Qi, Lei S and Sun, Yang},
title = {dCasMINI-mediated therapy rescues photoreceptors degeneration in a mouse model of retinitis pigmentosa},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adn7540}
}
EUVIMED